The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, single-arm, open-label trial of birociclib, a CDK4/6 inhibitor, as a single agent, in patients with refractory HR+/HER2- metastatic breast cancer.
 
Jiayu Wang
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Huiping Li
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Huihui Li
No Relationships to Disclose
 
Zhongsheng Tong
No Relationships to Disclose
 
Jingfen Wang
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Xinhong Wu
No Relationships to Disclose
 
Yuee Teng
No Relationships to Disclose
 
Jing Cheng
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Zhengqiu Zhu
No Relationships to Disclose
 
Chengkong Shi
Employment - Xuanzhu Biopharmaceutical Co., Ltd
 
Li Wang
Employment - Xuanzhu Biopharmaceutical Co., Ltd
 
Mingming Liu
Employment - Xuanzhu Biopharmaceutical Co., Ltd
 
Haiyan Xu
Employment - Xuanzhu Biopharmaceutical Co., Ltd
 
Xianghui Duan
Employment - Xuanzhu Biopharmaceutical Co., Ltd
 
Binghe Xu
No Relationships to Disclose